Steven J. Quinlan
Net Worth

Last updated:

What is Steven J. Quinlan net worth?

The estimated net worth of Mr. Steven J. Quinlan is at least $7,600,541 as of 11 Oct 2022. He owns shares worth $183,570 as insider, has earned $2,078,351 from insider trading and has received compensation worth at least $5,338,620 in Neogen Corporation.

What is the salary of Steven J. Quinlan?

Mr. Steven J. Quinlan salary is $381,330 per year as Vice President & Chief Financial Officer in Neogen Corporation.

How old is Steven J. Quinlan?

Mr. Steven J. Quinlan is 63 years old, born in 1962.

What stocks does Steven J. Quinlan currently own?

As insider, Mr. Steven J. Quinlan owns shares in one company:

Company Title Shares Price per share Total value
Neogen Corporation (NEOG) Vice President & Chief Financial Officer 32,722 $5.61 $183,570

What does Neogen Corporation do?

Neogen Corporation, together with its subsidiaries, develops, manufactures, and markets various products for food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells. This segment offers its products primarily to food and feed producers and processors; grain producers and processors; producers of cookies, crackers, candy, ice cream, and other processed foods; meat and poultry processors, seafood processors, fruit and vegetable producers, and dairies; laboratories; and producers of pharmaceuticals, cosmetics, and veterinary vaccines. The Animal Safety segment provides veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodenticides, cleaners, disinfectants, insecticides, and genomics testing services for the animal safety market. This segment offers various products for researchers to detect biologically active substances. Its drug detection immunoassay test kits are used for the detection of abused and therapeutic drugs in farm and racing animals; detection of drug residues in meat and meat products; and human forensic toxicology drug screening applications. In addition, this segment's products are used to maintain sanitary conditions and limit the potential hazards of bacteria, fungi, and viruses. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan.

NEOG logo
NEOG
Neogen Corporation
$5.61

Steven J. Quinlan insider trading

Neogen Corporation

Mr. Steven J. Quinlan has made 33 insider trades between 2011-2022, according to the Form 4 filled with the SEC. Most recently he purchased 5,000 units of NEOG stock worth $58,150 on 11 Oct 2022.

The largest trade he's ever made was exercising 35,000 units of NEOG stock on 27 Oct 2017. As of 11 Oct 2022 he still owns at least 32,722 units of NEOG stock.

Transaction Date Security Shares Price per share Total value Source
Purchase
Common Stock 5,000 $11.63 $58,150
Option
Restricted Stock Units 5,634 $28.4 $160,006
Option
Common Stock (Right to Buy) 29,448 $28.4 $836,323
Option
Restricted Stock Units 5,532 $40.85 $225,982
Option
Common Stock (Right to Buy) 34,912 $9.71 $338,996
Option
Common Stock (Right to Buy) 18,664 $20.23 $377,591
Sale
Common Stock 12,964 $43.69 $566,371
Option
Common Stock 12,964 $20.23 $262,275
Option
Common Stock 5,700 $20.23 $115,317
Sale
Common Stock 5,700 $44.05 $251,062
Sale
Common Stock 13,001 $60.43 $785,624
Option
Common Stock 13,001 $60.43 $785,624
Option
Common Stock (Right to Buy) 13,001 $60.43 $785,624
Option
Common Stock (Right to Buy) 15,000 N/A N/A
Sale
Common Stock 15,000 N/A N/A
Option
Common Stock 15,000 N/A N/A
Option
Common Stock (Right to Buy) 9,333 N/A N/A
Sale
Common Stock 9,333 N/A N/A
Option
Common Stock 9,333 N/A N/A
Sale
Common Stock 6,666 $70.54 $470,240
Option
Common Stock (Right to Buy) 6,666 $70.54 $470,240
Option
Common Stock 6,666 $70.54 $470,240
Option
Common Stock 800 N/A N/A
Option
Common Stock (Right to Buy) 800 N/A N/A
Sale
Common Stock 800 N/A N/A
Option
Common Stock (Right to Buy) 19,768 $68.3 $1,350,154
Option
Restricted Stock Unit 2,815 N/A N/A
Sale
Common Stock 899 N/A N/A
Option
Common Stock (Right to Buy) 899 N/A N/A
Option
Common Stock 899 N/A N/A
Sale
Common Stock 12,103 N/A N/A
Option
Common Stock (Right to Buy) 12,103 N/A N/A
Option
Common Stock 12,103 N/A N/A
Sale
Common Stock 8,031 N/A N/A
Option
Common Stock 8,031 N/A N/A
Option
Common Stock 4,801 N/A N/A
Option
Common Stock (Right to Buy) 4,801 N/A N/A
Sale
Common Stock 4,801 N/A N/A
Option
Common Stock 15,000 N/A N/A
Sale
Common Stock 15,000 N/A N/A
Purchase
Common Stock Right to Buy) 15,000 N/A N/A
Sale
Common Stock 6,902 N/A N/A
Option
Common Stock 6,902 N/A N/A
Option
Common Stock (Right to Buy) 6,902 N/A N/A
Sale
Common Stock 4,800 N/A N/A
Option
Common Stock (Right to Buy) 4,800 N/A N/A
Option
Common Stock 4,800 N/A N/A
Option
Common Stock (Right to Buy) 8,031 N/A N/A
Option
Common Stock 3,600 N/A N/A
Sale
common Stock 3,600 N/A N/A
Option
Common Stock (Right to Buy) 3,600 N/A N/A
Sale
Common Stock 3,802 N/A N/A
Option
Common Stock (Right to Buy) 3,802 N/A N/A
Option
Common Stock 3,802 N/A N/A
Option
Common Stock (Right to Buy) 5,000 N/A N/A
Option
Common Stock 5,000 N/A N/A
Sale
Common Stock 5,000 N/A N/A
Option
Common Stock 5,000 N/A N/A
Sale
Common Stock 5,000 N/A N/A
Option
Common Stock (Right to Buy) 5,000 N/A N/A
Option
Common Stock 2,866 N/A N/A
Option
Common Stock (Right to Buy) 2,866 $32.52 $93,214
Option
Common Stock (Right to Buy) 2,866 N/A N/A
Sale
Common Stock 2,866 N/A N/A
Option
Common Stock 2,866 $32.52 $93,214
Sale
Common Stock 2,000 N/A N/A
Option
Common Stock 2,000 N/A N/A
Option
Common Stock (Right to Buy) 2,000 N/A N/A
Sale
Common Stock 4,000 N/A N/A
Option
Common Stock 4,000 N/A N/A
Option
Common Stock (Right to Buy) 4,000 N/A N/A
Option
Common Stock (Right to Buy) 35,000 N/A N/A
Sale
Common Stock 2,250 N/A N/A
Option
Common Stock (Right to Buy) 2,250 N/A N/A
Option
Common Stock 2,250 N/A N/A
Sale
Common Stock 2,772 N/A N/A
Option
Common Stock 2,772 N/A N/A
Option
Common Stock (Right to Buy) 2,772 N/A N/A
Sale
Common Stock 4,000 N/A N/A
Option
Common Stock (Right to Buy) 4,000 N/A N/A
Sale
Common Stock 2,676 N/A N/A
Option
Common Stock 2,676 N/A N/A
Option
Common Stock (Right to Buy) 2,676 N/A N/A
Option
Common Stock 5,352 N/A N/A
Sale
Common Stock 5,352 N/A N/A
Option
Common Stock (Right to Buy) 5,352 N/A N/A
Option
Common Stock (Right to Buy) 3,000 N/A N/A
Option
Common Stock 3,000 N/A N/A
Sale
Common Stock 3,000 N/A N/A
Sale
Common Stock 3,000 N/A N/A
Option
Common Stock 3,000 N/A N/A
Option
Common Stock (Right to Buy) 3,000 N/A N/A
Sale
Common Stock 3,000 N/A N/A
Option
Common Stock 3,000 N/A N/A
Option
Common Stock (Right to Buy) 3,000 N/A N/A
Purchase
Common Stock 2,236 N/A N/A
Purchase
Common Stock 1,060 N/A N/A
Option
Common stock 3,000 N/A N/A
Option
Common Stock (Right to Buy) 3,000 N/A N/A
Option
Common Stock 1,500 N/A N/A
Sale
Common Stock 1,500 N/A N/A
Option
Common Stock ( Right to Buy) 1,500 N/A N/A
Option
Common Stock (Right to Buy) 1,500 N/A N/A
Sale
Common Stock 1,500 N/A N/A
Option
Common Stock 1,500 N/A N/A
Option
Common Stock 4,000 N/A N/A
Purchase
Common Stock 931 N/A N/A
Option
Common Stock (Right to Buy) 1,500 N/A N/A
Option
Common Stock 1,500 N/A N/A
Sale
Common Stock 1,500 N/A N/A
Option
Common Stock 291 N/A N/A
Option
Common Stock (Right to Buy) 1,000 N/A N/A
Purchase
Common Stock 3,213 $31.12 $99,989
Sale
Common Stock 147 $34.38 $5,054
Purchase
Common Stock 500 N/A N/A

Neogen key executives

Neogen Corporation executives and other stock owners filed with the SEC: